These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 35134495)

  • 21. Circ_0076305 regulates cisplatin resistance of non-small cell lung cancer via positively modulating STAT3 by sponging miR-296-5p.
    Dong Y; Xu T; Zhong S; Wang B; Zhang H; Wang X; Wang P; Li G; Yang S
    Life Sci; 2019 Dec; 239():116984. PubMed ID: 31647948
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Circular RNA-AnnexinA7 accelerates cisplatin resistance in non-small cell lung cancer via modulating microRNA-545-3p to mediate Cyclin D1.
    Yao J; Zhang HY; Gu S; Zou JL; Zhang Q; Qu RC
    Acta Biochim Pol; 2023 May; 70(2):295-304. PubMed ID: 37220402
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Exosome-transmitted circVMP1 facilitates the progression and cisplatin resistance of non-small cell lung cancer by targeting miR-524-5p-METTL3/SOX2 axis.
    Xie H; Yao J; Wang Y; Ni B
    Drug Deliv; 2022 Dec; 29(1):1257-1271. PubMed ID: 35467477
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Circ_0010235 confers cisplatin resistance in lung cancer by upregulating E2F7 through absorbing miR-379-5p.
    Wang L; Wang D; Xu Z; Qiu Y; Chen G; Tan F
    Thorac Cancer; 2023 Jul; 14(20):1946-1957. PubMed ID: 37277864
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Circular RNA circ_0005667 promotes cisplatin resistance of endometrial carcinoma cells by regulating IGF2BP1 through miR-145-5p.
    Sun G; Tian J; Xiao Y; Zeng Y
    Anticancer Drugs; 2023 Aug; 34(7):816-826. PubMed ID: 36728962
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CircRNA_100565 contributes to cisplatin resistance of NSCLC cells by regulating proliferation, apoptosis and autophagy via miR-337-3p/ADAM28 axis.
    Zhong Y; Lin H; Li Q; Liu C; Shen J
    Cancer Biomark; 2021; 30(2):261-273. PubMed ID: 33682697
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Circ_0030411 aggravates cisplatin-resistance in non-small cell lung cancer by serving as a miR-495-3p sponge to enhance CCND1 expression.
    Zhang J; Cui X; Qu H; Zhang Y
    J Chemother; 2023 Oct; 35(6):550-562. PubMed ID: 36591727
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Circ_0007841 knockdown confers cisplatin sensitivity to ovarian cancer cells by down-regulation of NFIB expression in a miR-532-5p-dependent manner.
    Gao Y; Huang Y
    J Chemother; 2023 Apr; 35(2):117-130. PubMed ID: 35380509
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Circ_0072088 knockdown contributes to cisplatin sensitivity and inhibits tumor progression by miR-944/LASP1 axis in non-small cell lung cancer.
    Zhang L; Wu Y; Hou C; Li F
    J Gene Med; 2022 May; 24(5):e3414. PubMed ID: 35106879
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Circ_0025039 acts an oncogenic role in the progression of non-small cell lung cancer through miR-636-dependent regulation of CORO1C.
    Wang L; Zeng C; Chen Z; Qi J; Huang S; Liang H; Huang S; Ou Z
    Mol Cell Biochem; 2022 Mar; 477(3):743-757. PubMed ID: 35034254
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Circular RNA circ_0003028 contributes to tumorigenesis by regulating GOT2 via miR-1298-5p in non-small cell lung cancer.
    Guan H; Sun C; Gu Y; Li J; Ji J; Zhu Y
    Bioengineered; 2021 Dec; 12(1):2326-2340. PubMed ID: 34077306
    [TBL] [Abstract][Full Text] [Related]  

  • 32. LncRNA SNHG12 Decreases Non-Small Cell Lung Cancer Cell Sensitivity to Cisplatin by Repressing miR-525-5p and Promoting XIAP.
    Tan D; Wang S; Zhang P; Peng C; Wu T
    Ann Clin Lab Sci; 2023 Jan; 53(1):64-75. PubMed ID: 36889771
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Circular RNA hsa_circ_0068252 Functions in Cisplatin Resistance and Immune Response via miR-1304-5p/PD-L1 Axis in Non-Small Cell Lung Cancer.
    Li J; Xu J; Wu G; Ren Y; Wang X; Zhang Q
    Chemotherapy; 2022; 67(4):223-233. PubMed ID: 35649347
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MiR-200c-3p and miR-485-5p overexpression elevates cisplatin sensitivity and suppresses the malignant phenotypes of non-small cell lung cancer cells through targeting RRM2.
    Liu Y; Zhang Y; Li Q; Xu R; Huang N
    Thorac Cancer; 2022 Jul; 13(13):1974-1985. PubMed ID: 35599447
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Circ_SETD3 regulates gefitinib sensitivity and tumor progression by miR-873-5p-dependent regulation of APPBP2 in non-small cell lung cancer.
    Sheng J; Liu L; Dong T; Wu X
    J Chemother; 2022 Oct; 34(6):401-413. PubMed ID: 34861803
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Upregulation of Long Noncoding RNA (lncRNA) X-Inactive Specific Transcript (XIST) is Associated with Cisplatin Resistance in Non-Small Cell Lung Cancer (NSCLC) by Downregulating MicroRNA-144-3p.
    Tian LJ; Wu YP; Wang D; Zhou ZH; Xue SB; Zhang DY; Wei YG; Liu W
    Med Sci Monit; 2019 Oct; 25():8095-8104. PubMed ID: 31659146
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Circ_0091537 promotes gefitinib chemoresistance in non-small cell lung cancer by mediating the miR-520h/YAP1 network.
    Qu R; Ma J
    Anticancer Drugs; 2023 Nov; 34(10):1151-1161. PubMed ID: 36727737
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Exosome-Derived Circ-PVT1 Contributes to Cisplatin Resistance by Regulating Autophagy, Invasion, and Apoptosis Via miR-30a-5p/YAP1 Axis in Gastric Cancer Cells.
    Yao W; Guo P; Mu Q; Wang Y
    Cancer Biother Radiopharm; 2021 May; 36(4):347-359. PubMed ID: 32799541
    [No Abstract]   [Full Text] [Related]  

  • 39. circ-LDLRAD3 Knockdown Reduces Cisplatin Chemoresistance and Inhibits the Development of Gastric Cancer with Cisplatin Resistance through miR-588 Enrichment-Mediated SOX5 Inhibition.
    Liang Q; Chu F; Zhang L; Jiang Y; Li L; Wu H
    Gut Liver; 2023 May; 17(3):389-403. PubMed ID: 35975639
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hsa_circ_0007142 contributes to cisplatin resistance in esophageal squamous cell carcinoma via miR-494-3p/LASP1 axis.
    Chang N; Ge N; Zhao Y; Yang L; Qin W; Cui Y
    J Clin Lab Anal; 2022 May; 36(5):e24304. PubMed ID: 35312115
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.